Yu‐Ling Lin
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Drug Discovery top 5%
Papers in
- Biomaterials 11
- Nanoparticle-Based Drug Delivery 9
-
- RNA Interference and Gene Delivery 4
- Co-authors
- Ting-Yan Jian (4 shared papers)Shu-Yi Ho (7 shared papers)Chih‐Hung Chou (1 shared paper)Hsi‐Yuan Huang (1 shared paper)Hsien‐Da Huang (1 shared paper)Ching-Min Lin (1 shared paper)Chao-Fang Chu (1 shared paper)Tzu‐Hao Chang (1 shared paper)
- Journals
- Scientific Reports (5 papers)International Journal of Nanomedicine (3 papers)International Journal of Molecular Sciences (3 papers)Journal of Experimental & Clinical Cancer Research (3 papers)Molecules (3 papers)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Yu‐Ling Lin
119 papers receiving 4.4k citations
Yu‐Ling Lin's Hit Papers
Peers
Comparison fields: 5 of 142
- Cancer Research 1.5k
- Drug Discovery 10
- Molecular Biology 1k
- Biomaterials 181
- Molecular Medicine 82
Countries citing papers authored by Yu‐Ling Lin
This map shows the geographic impact of Yu‐Ling Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Ling Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Ling Lin more than expected).
Fields of papers citing papers by Yu‐Ling Lin
This network shows the impact of papers produced by Yu‐Ling Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Ling Lin. The network helps show where Yu‐Ling Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu‐Ling Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 126 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database Hit paper breakdown → | 2015 | 1646 |
| 2 | miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions Hit paper breakdown → | 2013 | 949 |
| 3 | 2007 | 185 | |
| 4 | 2011 | 123 | |
| 5 | 2013 | 122 | |
| 6 | 2016 | 83 | |
| 7 | 2004 | 70 | |
| 8 | 2018 | 65 | |
| 9 | 2020 | 59 | |
| 10 | 2020 | 51 | |
| 11 | 2014 | 49 | |
| 12 | 2016 | 45 | |
| 13 | 2016 | 44 | |
| 14 | 2019 | 43 | |
| 15 | 2019 | 35 | |
| 16 | 2021 | 30 | |
| 17 | 2012 | 28 | |
| 18 | 2019 | 28 | |
| 19 | 2021 | 28 | |
| 20 | 2012 | 27 |
About Yu‐Ling Lin
Yu‐Ling Lin is a scholar working on Biomaterials, Molecular Biology, Genetics, Cancer Research and Pharmacology, having authored 126 papers that have together received 4.5k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (9 papers), Radio Frequency Integrated Circuit Design (4 papers), Advanced Photocatalysis Techniques (4 papers), RNA Interference and Gene Delivery (4 papers), Immunotherapy and Immune Responses (4 papers), Glioma Diagnosis and Treatment (4 papers), Biosensors and Analytical Detection (4 papers) and Ultrasound and Hyperthermia Applications (3 papers). The work is most often cited by research in Cancer Research (1.5k citations), Drug Discovery (10 citations), Molecular Biology (1k citations), Biomaterials (181 citations) and Molecular Medicine (82 citations). Yu‐Ling Lin has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Ting-Yan Jian, Shu-Yi Ho, Chih‐Hung Chou, Hsi‐Yuan Huang, Hsien‐Da Huang, Ching-Min Lin, Chao-Fang Chu, Tzu‐Hao Chang, Yu‐Ting Tseng and Sheng‐Da Hsu. Their work appears in journals such as Scientific Reports, International Journal of Nanomedicine, International Journal of Molecular Sciences, Journal of Experimental & Clinical Cancer Research and Molecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.